Expression of Vascular Endothelial Growth Factor in Lymph Nodes in Stage I Non-small Cell Lung Cancer and Its Clinical Significance

XU Zhaohua,LI Mingwu,HU Shixin,WANG Jun,SUN Wei

2009-01-01

Abstract:Objective To detect the positive expression of vascular endothelial growth factor(VEGF) in the lymph nodes of patients with stage I non -small cell lung cancer (NSCLC)to confirm the presence of micrometastasis and study the correlation of NSCLC with recurrence,metastases and prognosis. Methods A total of 246 hilar and mediastinal lymph nodes were removed during surgery from 33 patients with completely resected stage I NSCLC which was confirmed by conventional histopathologic methods.The lymph ndoes were analyzed for micrometastasis by LSAB technology with VEGF as a micrometastatic marker. Results VEGF positive cells were detected in 12(4.9%)of 246 lymph nodes in 10 (30.3%) of 33 patients. There was a significant difference between the recurrence rate and the metastases rate of the patients with or without positive expression of VEGF(80.0% vs 26.1%,χ2 =7.015,P = 0.016). The median survival time of the patients with positive expression of VEGF was significantly shorter than that of the patients with negative expression of VEGF (21months vs.60months,P =0.016).The patients with positive expression of VEGF in the lymph nodes had a poor prognosis by both univariate(P = 0.004) and multivariate analysis(P = 0.004). Conclusion Immunohistochemical staining for VEGF is a valid method for detecting and assessing the micrometastasis in the lymph nodes of lung cancer patient. The detection of lymph nodal micrometastatic tumor cells by immunohistochemistry provides an accurate assessment of tumor staging and has powerful prognostic implication for completely resected stage I NSCLC patients and provides theoretical evidence for comprehensive treatment of stage I NSCI C patients.